Questions? +1 (202) 335-3939

Trusted News Since 1995

A service for beauty industry professionals · Sunday, May 11, 2025 · 811,574,452 Articles · 3+ Million Readers

News Search | All News Topics > Cosmetics News Topics: By Country | By State

Search Tips

Here you can find useful examples and description about searching the news archive. Read it carefully to get the best results. If you need more help, please contact us.

Quick Overview

Searching is case insensitive. Words music and mUSIC return the same results.
Some of the common words like the, is, etc. are not included in your search.

Search Term Syntax

The symbol "|" stands for OR and symbol "&" stands for AND.

Term	Description
\|	Using \| operator gives you articles for every keyword in the search term.
&	Using & operator gives you only those articles that contain all keywords in the string.
" " (quotation marks)	Using quotation marks limits your search for exact phrases.
* (asterisk sign)	Using an asterisk sign gives you variations of aroot keyword. You cannot use it in phrases.
(parenthesis)	You can use parenthesis to adjust the priority of your search phrase evaluation (as common math/boolean expressions).

Examples

Keywords (search phrase)	Description
music	will search for any articles that contain the word music
music \| band \| song	will search for articles containing any of the keywords
nhl & hockey	will search for articles containing both words. (Note: & can be omitted in this case)
"white house" \| senate	will search for articles containing the phrase white house or the word senate
"flower show" & tulip	will search for articles containing both the phrase flower show and the word tulip
bank*	will search for articles containing bank, banks, banking, banker etc. Using * (asterisk sign) gives you variations of the root keyword.
student* & ( protest* \| demonstrat* )	will search for articles containing the words student or students, etc. in combinations with protest, protests, demonstrate, demonstration, etc.

Need more help? Contact us at our helpdesk.

Published on May 10, 2025

Seborrheic Dermatitis vs Dandruff: What’s Causing Your Flakes?

towfiqu ahamed/istockphotoSeborrheic Dermatitis vs Dandruff This article was reviewed by Knox Beasley, MD. Flakes on your scalp making you feel self-conscious? Let’s talk about seborrheic dermatitis vs dandruff. Whether your scalp feels like a …

Source: AOL - Pending
Published on May 10, 2025

Temtokibart Shows Efficacy in Treatment of Atopic Dermatitis

Positive topline results have been announced from a phase 2b trial evaluating the efficacy and safety of temtokibart for the treatment of moderate to severe atopic dermatitis in adult patients, LEO Pharma announced in a release.1 The company said it is …

Source: Drug Topics - Neutral
Published on May 9, 2025

New-Onset Psoriasis After Abrocitinib Treatment for Atopic Dermatitis

The coexistence of AD and psoriasis in the same patient has been considered uncommon because of their differing T-cell lineages. AD is a chronic inflammatory skin disease affecting up to 10% of adults and 30% of children globally. It is primarily driven by …

Source: Dermatology Times - Neutral
Published on May 9, 2025

LEO Pharma Announces Positive Preliminary Phase 2b Findings for Temtokibart in Atopic Dermatitis

Temtokibart (LEO 138559), an investigational monoclonal antibody targeting the IL-22RA1 receptor subunit, achieved statistically significant improvements in eczema severity at the 3 highest tested doses in a phase 2b clinical trial of adults with moderate- …

Source: Patient Care - Pending
Published on May 9, 2025

Ivarmacitinib ‘promising’ for atopic dermatitis not controlled with topical therapies

This is a phase 3 randomized trial of ivarmacitinib, a JAK inhibitor with selectivity for JAK 1, for adolescents and adults with moderate to severe AD. The study is robust, with 336 participants and found that the ivarmacitinib was more effective than …

Source: Healio News - Neutral
Published on May 9, 2025

Corvus' Phase 1 atopic dermatitis data prompt stock rally

Source: Endpoints News - Neutral
Published on May 8, 2025

Switching Gears in Atopic Dermatitis: How Upadacitinib Helps Patients Reach Optimal Targets After Dupilumab Inadequacy

In the ever-evolving landscape of atopic dermatitis (AD) management, dermatologists are increasingly guided by the imperative to aim higher. The AHEAD consensus has redefined success, not just as partial symptom control, but as achievement of minimal …

Source: Dermatology Times - Neutral
Published on May 8, 2025

Corvus Pharmaceuticals Announces Data from Cohorts 1-3 of Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for ...

Data continue to demonstrate favorable safety and efficacy profile, including earlier and deeper responses in cohort 3 compared to cohorts 1-2 Data to be presented in an oral session and poster at the Society for Investigative Dermatology 2025 Annual …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 8, 2025

Unmet Needs in Atopic Dermatitis and the Impact of Roflumilast Cream, with Raj Chovatiya, MD, PhD

Roflumilast is a therapeutic option for many patients with inflammatory conditions such as atopic dermatitis. It was approved by the US Food and Drug Administration (FDA) in 2024 as roflumilast cream 0.15% for individuals aged 6 years and older with …

Source: Consultant Live - Pending
Published on May 8, 2025

Global Burden of Atopic Dermatitis in Older Adults Is Considerable

WEDNESDAY, May 7, 2025 (HealthDay News) — The global burden of atopic dermatitis (AD) in older adults is considerable and is expected to continue increasing to 2050, according to a study published online April 1 in Frontiers in Public Health. Yi Ou, from …

Source: Physician's Weekly - Neutral